HIV PRE-EXPOSURE PROPHYLAXIS
Clinical trials for HIV PRE-EXPOSURE PROPHYLAXIS explained in plain language.
Never miss a new study
Get alerted when new HIV PRE-EXPOSURE PROPHYLAXIS trials appear
Sign up with your email to follow new studies for HIV PRE-EXPOSURE PROPHYLAXIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
ERs could be front line against HIV: new study offers pills on the spot
Prevention Not yet recruitingThis study tests whether giving HIV prevention medication (PrEP) to people right in the emergency department helps them start and stay on treatment. About 250 adults at risk for HIV in Dallas will receive a same-day prescription and a follow-up appointment. The goal is to see if …
Matched conditions: HIV PRE-EXPOSURE PROPHYLAXIS
Phase: NA • Sponsor: University of Texas Southwestern Medical Center • Aim: Prevention
Last updated May 26, 2026 12:04 UTC
-
HIV prevention study seeks to find which injectable works best for patients
Prevention Not yet recruitingThis study looks at how satisfied people are with two different long-acting injectable HIV prevention medications (lenacapavir and cabotegravir). About 128 adults in Louisville, KY who are already using or starting one of these shots will fill out surveys and interviews over 12 m…
Matched conditions: HIV PRE-EXPOSURE PROPHYLAXIS
Sponsor: Anupama Raghuram MD • Aim: Prevention
Last updated May 26, 2026 12:03 UTC
-
New program aims to boost PrEP use among black women in the south
Prevention Not yet recruitingThis study tests a group program called EMPOWER to help Black women in the southern U.S. start and continue taking PrEP, a daily pill that prevents HIV. The program provides sexual health education and support. Researchers will enroll 80 women to see if the program is feasible an…
Matched conditions: HIV PRE-EXPOSURE PROPHYLAXIS
Phase: NA • Sponsor: University of Georgia • Aim: Prevention
Last updated May 18, 2026 11:58 UTC
-
New HIV prevention pill tested with TB treatment
Knowledge-focused Not yet recruitingThis early-stage study tests how a new HIV prevention drug (MK-8527) interacts with rifampin, a medicine for latent tuberculosis. Fourteen adults with latent TB will take both drugs, and researchers will measure drug levels in the blood. The goal is to see if the drugs can be use…
Matched conditions: HIV PRE-EXPOSURE PROPHYLAXIS
Phase: PHASE1 • Sponsor: Merck Sharp & Dohme LLC • Aim: Knowledge-focused
Last updated May 26, 2026 12:07 UTC
-
Can a phone-based program boost HIV prevention in rural drug users?
Knowledge-focused Not yet recruitingThis study tests whether an 8-session telehealth program can help people who inject drugs in the rural South build coping skills and resilience. The goal is to make it easier for them to access HIV prevention (PrEP) and hepatitis C care. The study will enroll 50 participants and …
Matched conditions: HIV PRE-EXPOSURE PROPHYLAXIS
Phase: NA • Sponsor: University of Georgia • Aim: Knowledge-focused
Last updated May 18, 2026 12:02 UTC